Efficacy and Safety of long-term high-flow nasal cannula oxygen therapy in stable COPD patients with home oxygen therapy (HOT): a multicenter, prospective, randomized controlled study - Study of long-term HFNC for COPD patients with HOT (FLOCOP study)

Kobe City Medical Center General Hospital Department of Respiratory Medicine0 个研究点目标入组 120 人开始时间: 2017年8月8日最近更新: 2023年10月17日

试验速览

阶段: 未知
状态: 已完成
发起方
入组人数: 120

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

暂无简介。

研究设计

研究类型: Interventional

入排标准

年龄范围: 40years-old 至 ot applicable（—）
性别: All

入选标准

未提供

排除标准

•1. Patients with severe kidney, liver or cardiovascular disease. 2. Patients with active malignant tumor. 3. Patients with acute disease. 4. Patients who are diagnosed with asthma. (Excluding COPD patients with history of asthma). 5. Patients who have any history of the diagnosis with obstructive sleep apnea syndrome (OSAS) or are highly-suspected cases in the clinical. (Excluding patients who are denied the diagnosis of OSAS by the result of overnight polysomnography.) 6. Patients with diseases that affecting the efficacy endpoints (for example: active pulmonary infection, clinically significant pulmonary fibrosis and bronchiectasis, a1-antitrypsin deficiency etc.,) and are regarded as inadequate for the study by the investigators. 7. Patients who have experienced a COPD exacerbation (any Severity: judged by the investigators) within the past 4 weeks prior to the informed consent. 8. Patients who are receiving nocturnal noninvasive positive pressure ventilation (NPPV), or who had been received it within 4 weeks prior to the informed consent. 9. Patients who have used HFNC at home within the past 1 year prior to the informed consent, or are using any HFNC. (Excluding patients who used HFNC during hospitalization due to acute respiratory failure within 1 year prior to the informed consent.) 10. Patients with history of tracheotomy, severe pharyngeal surgery or severe nasal cavity surgery within the past 6 months prior to the informed consent. 11. Patients who are pregnant. 12. Patients with cognitive impairment or mental disorder who are regarded as inadequate to evaluate for the study by the investigators. 13. Patients who are regarded as being unable to operate the myAIRVO2 adequately at home by the investigators. 14. Patients who have participated in the other study at the time of the informed consent, or will participate in the other study. 15. Any other cases who are regarded as inadequate for the study enrollment by the investigators.

研究者

发起方

Kobe City Medical Center General Hospital Department of Respiratory Medicine

相似试验

招募中

1 期

A study on safety and efficacy of high-flow nasal cannula attachable hydrogen gas generator for ARDS

JPRN-jRCTs062220003akao Atsunori40

已完成

不适用

Study of Long-term HFNC for COPD Patients with HOTChronic Obstructive Pulmonary Disease (COPD)

NCT03282019Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan120

已完成

不适用

Evaluation of the effectiveness of high flow oxygen delivery through the nasal cannula in comparison with non-invasive ventilation in patients with COVID-19COVID-19.Coronavirus infection, unspecifiedB34.2

IRCT20160516027929N8Shahid Beheshti University of Medical Sciences60

尚未招募

1 期

Safety and Efficacy of Chula High Flow Nasal CannulaPhase 1 Healthy group Phase 2 COVID-19 with respiratory failureHigh flow nasal cannulaCOVID-19Acute respiratory failurePneumonia

TCTR20210825007/A15

招募中

不适用

Efficacy of Nasal High Flow therapy on the coordination between breathing and swallowing of saliva during daytime nap in COPD patients.COPD

JPRN-jRCTs072200014Ayuse Takao15